Key Takeaways:
- Q2 revenue hit $5.55M, up 9,000% from $61,000 a year earlier
- Net loss narrowed to $11.8M from $36.5M on warrant derivative write-downs
- Analyst upgraded QUBT to Buy at $8.30, citing $1.3B cash and $42.5M backlog
Key Takeaways:

Quantum Computing Inc. reported Q2 revenue of $5.55 million, a 9,000 percent surge from $61,000 a year earlier, as photonics product shipments to government agencies, academic institutions, and commercial enterprises accelerated.
"QCi has developed much further while its valuation has become less extreme," a Seeking Alpha analyst said in an Aug. 22 note upgrading the stock from Hold to Buy at $8.30.
Revenue beat the $5.15 million consensus by $400,000. Adjusted loss of $0.05 per share missed the $0.03 consensus. The net deficit narrowed to $11.8 million from $36.5 million, driven primarily by reduced warrant derivative write-downs rather than operational improvements.
Roughly $5.1 million of Q2 revenue came from acquired businesses — Luminar Semiconductor, NuCrypt, and NHanced. Cost of revenue reached $6.72 million, producing a gross loss of $1.17 million and a negative 21 percent gross margin. Operating expenses climbed 114 percent year-over-year to $21.8 million, reflecting the NHanced acquisition that opened a second chip fabrication facility.
The company ended Q2 with $42.5 million in contract backlog — nearly eight times quarterly revenue — and $1.3 billion in cash and equivalents against $47.2 million in liabilities. Shares outstanding rose 43 percent year-over-year to 226.3 million, as QCi raised about $1.64 billion in stock since November 2024.
The stock trades at $8.30, down 58 percent from June 2025. Market cap stands at $1.88 billion, while cash-adjusted enterprise value is roughly $580 million — about 20 times expected 2026 revenue of $28.7 million. Wall Street consensus remains Hold with a mean price target of $18.33, spanning four Buy, two Hold, and one Sell rating.
The move came as quantum computing equities traded in unison on Aug. 21, with D-Wave (QBTS) rising as much as 7 percent after BMO Capital Markets initiated coverage with an Outperform rating, Rigetti (RGTI) gaining 9.6 percent, and IonQ (IONQ) advancing 7.5 percent.
Barron's questioned whether the growth surge is sustainable, noting most of the revenue increase was purchased through acquisitions rather than organic operations. A securities class action is pending against QCi and various current and former directors alleging misleading statements about customers, contracts, and business operations.
The analyst's five-year outlook projects $400 million to $500 million in revenue by 2031, implying a stock price near $13.75. Investors will watch whether QCi can achieve positive gross margins and organic growth in coming quarters, with consensus expecting losses through at least 2028.
This article is for informational purposes only and does not constitute investment advice.